7613. Efficacy of commercial weight-loss programs: an updated systematic review.
作者: Kimberly A Gudzune.;Ruchi S Doshi.;Ambereen K Mehta.;Zoobia W Chaudhry.;David K Jacobs.;Rachit M Vakil.;Clare J Lee.;Sara N Bleich.;Jeanne M Clark.
来源: Ann Intern Med. 2015年162卷7期501-12页
Commercial and proprietary weight-loss programs are popular obesity treatment options, but their efficacy is unclear.
7614. The optimal imaging strategy for patients with stable chest pain: a cost-effectiveness analysis.
作者: Tessa S S Genders.;Steffen E Petersen.;Francesca Pugliese.;Amardeep G Dastidar.;Kirsten E Fleischmann.;Koen Nieman.;M G Myriam Hunink.
来源: Ann Intern Med. 2015年162卷7期474-84页
The optimal imaging strategy for patients with stable chest pain is uncertain.
7615. Surgery versus nonsurgical treatment of lumbar spinal stenosis: a randomized trial.
作者: Anthony Delitto.;Sara R Piva.;Charity G Moore.;Julie M Fritz.;Stephen R Wisniewski.;Deborah A Josbeno.;Mark Fye.;William C Welch.
来源: Ann Intern Med. 2015年162卷7期465-73页
Primary care management decisions for patients with symptomatic lumbar spinal stenosis (LSS) are challenging, and nonsurgical guidance is limited by lack of evidence.
7618. The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.
作者: Benjamin P Linas.;Devra M Barter.;Jake R Morgan.;Mai T Pho.;Jared A Leff.;Bruce R Schackman.;C Robert Horsburgh.;Sabrina A Assoumou.;Joshua A Salomon.;Milton C Weinstein.;Kenneth A Freedberg.;Arthur Y Kim.
来源: Ann Intern Med. 2015年162卷9期619-29页
Chronic infection with hepatitis C virus (HCV) genotype 2 or 3 can be treated with sofosbuvir without interferon. Because sofosbuvir is costly, its benefits should be compared with the additional resources used.
7619. Routine iron supplementation and screening for iron deficiency anemia in pregnancy: a systematic review for the U.S. Preventive Services Task Force.
作者: Amy G Cantor.;Christina Bougatsos.;Tracy Dana.;Ian Blazina.;Marian McDonagh.
来源: Ann Intern Med. 2015年162卷8期566-76页
Routine screening and supplementation for iron deficiency anemia (IDA) in asymptomatic, nonanemic pregnant women could improve maternal and infant health outcomes.
|